novo nordisk glp 1 drugs promotes new GLP-1 receptor agonist to fight diabetes, obesity < Pharma < Article The GLP-1 Race - VERUS

doi:10.3109/15563650.2014.902956

Many patients starting tirzepatide therapy wonder whether the weekly injection will cause significant pain or discomfort

How we survived and are still here to tell the tail

Kisspeptin is a neuropeptide produced by neurons in the arcuate and anteroventral periventricular nuclei of the hypothalamus

Its ability to enhance synaptogenesis, accelerate wound healing, and protect neurons positions it as a frontier therapy in age-related decline

(Some GLP-1 agonists have been around for nearly two decades.) A lot of people who experience the common side effects tend to feel better as they continue on the medications, not worse